Carla Smith, the Executive Vice President of HIMSS North America issued the following statement on October 6, 2015, regarding the Meaningful Use Stage 3 Rule.
IT is a critical tool enabling positive transformation, value-based care models, and the delivery of better care, improved outcomes, and lower costs. In response to the new final regulations released today, HIMSS appreciates the continued efforts of CMS and ONC to simplify and provide flexibility for meeting the Meaningful Use program requirements. We support the confirmation of the 90-day reporting period for 2015. Further, we support the emphasis placed on January 1, 2018 – the start of the period where providers are required to meet Stage 3 objectives and measures.
Consistently, HIMSS has called for at least 18 months between the publication of a new Meaningful Use rule and the start of a new Stage’s reporting period—the 27 months provided in this final rule appears to address this issue. HIMSS encourages reasonable Meaningful Use-related rules and timelines, as these enable providers to continue their participation in the program, thus supporting a positively transformed health system.